Measuring Parkinson's Disease Progression
NCT03205956
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
Levodopa
Sponsor
Kevin J. Black, MD
Collaborators
[object Object]